Rogaine 5% minoxidil solution targeted only to men due to lack of data in women.
This article was originally published in The Tan Sheet
Executive Summary
ROGAINE EXTRA STRENGTH "NOT FOR USE BY WOMEN" HIGHLIGHTED IN LABELING proposed by Pharmacia & Upjohn for the anti-baldness treatment. The company is attempting to gain approval for Rogaine 5% minoxidil solution as a direct-to-OTC product. The NDA (20-834) was the topic of a July 16 joint meeting of FDA's Nonprescription Drugs and Dermatologic & Ophthalmic Drugs Advisory Committees in Bethesda, Md.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning